In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Hot Line I - Cardiovascular disease: novel therapies

ESC Congress 2014, Barcelona - press conference

Date & Time:  Saturday 30 August, 13:00-14:00
Refers to session: Hot Line I - Cardiovascular disease: novel therapies

Chairpersons
Prof. Hector Bueno (Netherlands)
Prof. Mariell Jessup (USA)
Spokesperson
Prof. Hans-Joachim Nesser (Austria)
Prof. Francois Schiele (France)

Prof. Hans-Joachim Nesser Prof. Francois Schiele  


COlchicine for Prevention of the Post-pericardiotomy Syndrome and
Post-operative Atrial Fibrillation (COPPS-2 trial)

Dr Massimo Imazio, Maria Vittoria Hospital (Turin, Italy)
Press release  |  Slides 

 

 

A randomized controlled trial of vagal stimulation for the treatment of systolic heart failure:  NEural Cardiac TherApy foR Heart Failure (NECTAR-HF)

Prof. Faiez Zannad, Centre D'investigation Clinique, Chu De Nancy (Nancy, France)
Press release  |  Slides 

 

Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

Dr Milton Packer, Ut Southwestern Medical Center (New York, USA)
Press release  |  Slides

 

 

Effect of ferric carboxymaltose on functional capacity in patients with heart failure and iron deficiency (CONFIRM)

Prof. Piotr Ponikowski, Medical University, Centre For Heart Disease (Wroclaw, Poland)
Press release  |  Slides

 

 

Cardiac resynchronization therapy with a novel quadripolar lead decreases complications at six months: preliminary results of the MORE-CRT trial

Prof. Giuseppe Boriani, Institute Of Cardiology, Univ. Of Bologna (Bologna, Italy)
Press release  |  Slides

 

 

Colchicine for Post- operative Pericardial Effusion: The post-operative pericardial effusion (POPE-2) Study. A multicenter, double-blind, randomized trial

Dr Philippe Meurin,  Centre De Readapt. Cardiaque Les Grands Pres (Villeneuve Saint denis, France)
Press release  |  Slides

 

 




Abstracts linked to ESC press conferences are not available until embargo lifts. The embargo lifts at the beginning of the press conference or the scientific session, whichever comes first. All other abstracts will be online on 22 August, 2014 in the Scientific Programme Planner except for Hot Lines, Clinical Trial Update and Registries Hot Lines abstracts.
Press releases are available on site in the press kit (USB key) that you will receive once you pick up your badge at the press registration desk at ESC Congress 2014 - except for press releases on Clinical Trial Updates and Hot Line sessions which are only available when the embargo lifts.
Press slides will be available at the beginning of the press conference.
All ESC Press conferences will be broadcast live. Unfortunately, no webcast will be available. Access to the session will be restricted to registered press only.
During the ESC Congress 2014, all scientific resources are available on ESC Congress 365.